‘A silent killer’: COVID-19 shown to trigger inflammation in the brain

Strong RSV vaccine data lifts hopes after years of futility
1 November 2022
Medical trial finds ticagrelor–aspirin antiplatelet therapy more beneficial in persons with normal renal function
1 November 2022

‘A silent killer’: COVID-19 shown to trigger inflammation in the brain

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease.

Comments are closed.